Education
About Us
Working with TipRanks
Follow Us
Astrana Health Inc. (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
$18.59
$0.06(0.19%)
At close: 4:00 PM EST
$18.59
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$18.08 - $34.80
Previous CloseN/A
Volume92.25K
Average Volume (3M)628.21K
Market Cap
$1.26B
Enterprise Value$1.90B
Total Cash (Recent Filing)$429.47M
Total Debt (Recent Filing)$1.08B
Price to Earnings (P/E)54.1
Beta0.98
Next Earnings
May 13, 2026EPS Estimate
0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding50,155,613
10 Day Avg. Volume677,235
30 Day Avg. Volume628,206
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)1.56
Price to Sales (P/S)0.38
P/FCF Ratio11.65
Enterprise Value/Market Cap1.51
Enterprise Value/Revenue0.60
Enterprise Value/Gross Profit6.13
Enterprise Value/Ebitda14.75
Forecast
1Y Price Target
$35.00Price Target Upside88.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)1.23
Revenue Forecast (FY)$3.96B
Bulls Say, Bears Say
Bulls Say
Acquisition SynergiesIntegration of the Prospect Health acquisition is expected to deliver meaningful synergies and automation-driven efficiencies that could lift margins and improve cash flow.
EarningsAdjusted EBITDA beat analyst consensus, driven by stronger-than-expected revenues in the Care Partners division and delivery services, signaling improving operating performance.
Revenue ModelA move toward fully capitated contracts is expected to enhance revenue predictability and earnings quality by shifting a larger portion of revenue to fixed-risk arrangements.
Bears Say
GovernanceExtension of the annual report filing due to timing and documentation of control procedures raises governance scrutiny and could elevate investor uncertainty until procedures are finalized.
Guidance RiskManagement set guidance below analyst consensus and provided a detailed bridge that implies downside risk if bridging items underperform, increasing the likelihood of earnings misses.
Regulatory RiskA proposed rule to disallow diagnoses from audio-only encounters and certain chart review methods could reduce recognized diagnoses and pressure risk-adjusted revenue for companies that relied on those sources.
Astrana Health News
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $18.08 and its highest was $34.80 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $1.26B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is May 13, 2026 which is in 67 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on Mar 04, 2026. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.106 by $0.014.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.27.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 50,155,613 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.12 in its last earnings report, beating expectations of $0.106. Following the earnings report the stock price went up 4.406%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$35.00 (88.27% Upside)
$35.00 (88.27% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 184.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.3%
Last 30 Days ▼ 8.7%
Last 30 Days ▼ 8.7%
News Sentiment
Very Bullish
Bullish news 88%
Bearish news 13%
Bearish news 13%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.79%
12-Months-Change
Fundamentals
Return on Equity
3.01%
Trailing 12-Months
Asset Growth
61.29%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
ASTH Company Deck
ASTH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized multiple record financial and operating milestones—strong double‑digit top-line growth, record adjusted EBITDA and free cash flow, expanding geographic diversification, measurable operating leverage from the platform and AI, and progressing integration synergies from the Prospect acquisition. Management acknowledged near-term headwinds including a material weakness in controls (Form 12b-25), elevated 2026 cost assumptions, Medicaid/exchange disenrollment risk, transaction-related one-time costs, and leverage that create measurable but manageable risk. Guidance is framed conservatively with clear paths to the midpoint driven by realized synergies, ramping full-risk contracts, and AI-driven efficiencies.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$35.00
▲(88.27% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
47.34% Insiders
17.66% Mutual Funds
6.65% Other Institutional Investors
7.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---